Alnylam Pharmace. buy kyron7htx
Start price
05.02.19
/
50%
€76.96
Target price
07.02.19
€108.24
Performance (%)
-5.47%
End price
07.02.19
€72.75
Summary
This prediction ended on 07.02.19 with a price of €72.75. With a performance of -5.47%, the BUY prediction by kyron7htx finished with a loss. kyron7htx has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -13.930% | -13.930% | 40.381% | 54.154% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by kyron7htx for this prediction
In the thread Alnylam Pharmace. diskutieren
(Stop Loss Kurs erreicht)
Stopped prediction by kyron7htx for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€69.33
08.02.19
08.02.19
€108.24
04.11.21
04.11.21
116.51%
17.07.21
17.07.21
